Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients

BACKGROUND: Whether metformin may reduce the risk of uterine leiomyoma in type 2 diabetes patients has not been investigated. This retrospective cohort study compared the risk of uterine leiomyoma in ever versus never users of metformin. METHODS: Female patients with new-onset type 2 diabetes during...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920594/
https://www.ncbi.nlm.nih.gov/pubmed/31897287
http://dx.doi.org/10.1177/2042018819895159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920594/
https://www.ncbi.nlm.nih.gov/pubmed/31897287
http://dx.doi.org/10.1177/2042018819895159

Ejemplares similares